Skip to main content

VXR 107 (Venlafaxine Hydrochloride Extended-Release 150 mg)

Pill with imprint VXR 107 is Red, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended-Release 150 mg. It is supplied by Orchid Healthcare.

Venlafaxine is used in the treatment of autism; anxiety; depression; generalized anxiety disorder; major depressive disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for VXR 107

Venlafaxine Hydrochloride Extended-Release

Imprint
VXR 107
Strength
150 mg
Color
Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Orchid Healthcare
National Drug Code (NDC)
68820-0107
Inactive Ingredients
povidone k90, magnesium silicate, ethylcellulose (100 mPa.s), polyethylene glycol 400, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide, sodium lauryl sulfate, shellac, potassium hydroxide, sucrose, alcohol, butyl alcohol, isopropyl alcohol, propylene glycol, ammonia, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.